[1] |
Aithal GP, Breslin NP, Gumustop B. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 345(2): 147-148.
doi: 10.1056/NEJM200107123450215
URL
|
[2] |
Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021: 31(3): 529-533.
doi: 10.1080/14397595.2020.1859710
URL
|
[3] |
Boffa JJ, Esteve E, Buob D. Renal involvement in IgG4-related disease[J]. Presse Med, 2020, 49(1): 104017.
doi: 10.1016/j.lpm.2020.104017
URL
|
[4] |
Ebbo M, Daniel L, Pavic M, et al. Schleinitz, IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry[J]. Medicine (Baltimore), 2012, 91(1): 49-56.
doi: 10.1097/MD.0b013e3182433d77
URL
|
[5] |
Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients[J]. PLoS One, 2017, 12(9): e0183844.
|
[6] |
Nakashima H, Kawano M, Saeki T, et al. Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry(J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings[J]. Clin Exp Nephrol, 2017, 21(1): 97-103.
doi: 10.1007/s10157-016-1260-1
pmid: 27015831
|
[7] |
Saeki T, Kawano M, Nagasawa T, et al. Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version[J]. Clin Exp Nephrol, 2021, 25(2): 99-109.
doi: 10.1007/s10157-020-01993-7
URL
|
[8] |
Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care[J]. Nat Rev Rheumatol, 2020. 16(12): 702-714.
doi: 10.1038/s41584-020-0500-7
URL
|
[9] |
Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis[J]. Am J Kidney Dis, 2004, 43(3): e18-e25.
|
[10] |
Martín-Nares E, Hernandez-Molina G, Rodríguez-Ramírez S, et al. IgG4-related kidney disease: experience from a Mexican cohort[J]. Clin Rheumatol, 2020, 39(11): 3401-3408.
doi: 10.1007/s10067-020-05135-y
URL
|
[11] |
Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients[J]. Arthritis Rheumatol, 2015, 67(9):2466-2475.
doi: 10.1002/art.39205
URL
|
[12] |
Wang L, Zhang P, Zhang X, et al. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients[J]. Rheumatology (Oxford), 2019, 58(5): 820-830.
doi: 10.1093/rheumatology/key397
URL
|
[13] |
Yamada K, Yamamoto M, Saeki T, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases[J]. Arthritis Res Ther, 2017, 19(1): 262.
doi: 10.1186/s13075-017-1467-x
URL
|
[14] |
Evans RDR, Cargill T, Goodchild G, et al. Clinical manifestations and long-term outcomes of IgG4-related kidney and retroperitoneal involvement in a United Kingdom IgG4-related disease cohort[J]. Kidney Int Rep, 2019, 4(1): 48-58.
doi: 10.1016/j.ekir.2018.08.011
pmid: 30596168
|
[15] |
Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease(IgG4RD): general concept and details[J]. Mod Rheumatol, 2012, 22(1): 1-14.
doi: 10.3109/s10165-011-0508-6
URL
|
[16] |
Ling J, Wang H, Pan W, et al. Clinical and imaging features of IgG4-related kidney disease[J]. Abdom Radiol (NY), 2020, 45(6): 1915-1921.
|
[17] |
Kuruma S, Kamisawa T, Kikuyama M, et al. Clinical characteristics of autoimmune pancreatitis with IgG4 related kidney disease[J]. Adv Med Sci, 2019, 64(2): 246-251.
doi: 10.1016/j.advms.2018.12.005
URL
|
[18] |
Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699.
doi: 10.1002/art.39132
URL
|
[19] |
Akiyama M, Yasuoka H, Yamaoka K, et al. Enhanced IgG 4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease[J]. Arthritis Res Ther, 2016, 18:167.
doi: 10.1186/s13075-016-1064-4
URL
|
[20] |
Della-Torre E, Bozzalla-Cassione E, Sciorati C, et al. A CD8α- subset of CD4+SLAMF7+ cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment[J]. Arthritis Rheumatol, 2018, 70(7): 1133-1143.
doi: 10.1002/art.40469
URL
|